FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely therapy and surgery, and can be used for treating metabolic syndrome, including in patients suffering cardiovascular and respiratory insufficiency, and also obstructive sleep apnea. That is ensured by brief noninvasive continuous positive pressure assisted ventilation for 3 days (CPAP-therapy). The compensation is followed by inserting an intragastric cylinder and continuing the long-term CPAP-therapy to eliminate sleep apnea completely.
EFFECT: method provides compensating metabolic syndrome by manifested body weight reduction ensured by enabled insertion of the intragastric cylinder together with a reduced risk of developing complications accompanying the insertion due to the advance compensation of the detected disorders.
1 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINATION OF INDICATIONS FOR POLYSOMNOGRAPHY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2009 |
|
RU2412644C1 |
| METHOD FOR DETERMINATION OF INDICATIONS FOR NASAL OBSTRUCTION RELEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2009 |
|
RU2402264C1 |
| METHOD OF FORMING RISK GROUP OF OBSTRUCTIVE SLEEP APNOEA/HYPOPNOEA SYNDROME | 2022 |
|
RU2818636C1 |
| METHOD OF TREATING PATIENTS WITH HYPOGONADISM WITH SYNDROME OF OBSTRUCTIVE SLEEP APNEA | 2007 |
|
RU2383346C2 |
| METHOD OF FORECASTING OF RESPIRATION DISTURBANCE IN SLEEP IN OBESE CHILDREN | 2008 |
|
RU2394241C2 |
| METHOD FOR PREDICTING DEVELOPMENT OF OBSTRUCTIVE SLEEP APNOEA SYNDROME IN ADOLESCENT BOYS SUFFERING OBESITY | 2020 |
|
RU2739689C1 |
| THERAPY OF SNORING DUE TO LOCAL D'ARSONVAL TREATMENT | 2005 |
|
RU2308983C2 |
| METHOD FOR DETERMINING RESPIRATORY, CARDIOVASCULAR AND METABOLIC DISORDERS RISK DEGREE IN PATIENTS SUFFERING FROM DESTRUCTIVE RESPIRATION DISORDERS IN SLEEPING | 2005 |
|
RU2308886C2 |
| METHOD OF TREATING SLEEP DISTURBANCES IN BOYS WITH OBESITY | 2012 |
|
RU2479841C1 |
| METHOD FOR PREDICTION OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2793677C1 |
